Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
LFXClass II

Enzyme Linked Immunoabsorbent Assay, Rubella

21 CFR 866.3510 / Microbiology

LFX is the FDA product code for Enzyme Linked Immunoabsorbent Assay, Rubella, a class II device type, regulated under 21 CFR 866.3510. As of , FDA records hold 94 510(k) clearances under this code, the most recent dated , and 15 recalls.

Classification record

Product code
LFX
Device name
Enzyme Linked Immunoabsorbent Assay, Rubella
Regulation
21 CFR 866.3510
Device class
Class II
Review panel
Microbiology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
Yes
Ingested clearances
94
Ingested recalls
15

Clearances, product code LFX

By decision year
94 clearances under product code LFX with a decision year between 1979 and 2025, 1989 the highest year at 17.
Show the numbers
510(k) clearances under FDA product code LFX by decision year
YearClearances
19791
19813
19822
19831
19841
19866
19875
19885
198917
19907
19913
19926
19942
19952
19969
19971
19983
19993
20002
20012
20021
20031
20061
20071
20083
20102
20111
20121
20252

Applicants with the most clearances

Product code LFX

Companies listing this code with FDA

Companies whose registered establishments list this code

12 of 28 companies shown, in name order